| |
TDT group (n = 33)
|
CMS group (n = 26)
|
p value
|
|---|
|
Tumor size, cm (range)*
|
4.5 (3.0–9.0)
|
5.5 (3.5–11.0)
|
0.008
|
|
Histological type (%)
|
0.470
|
|
Tub 1
|
11 (33.3)
|
7 (26.9)
| |
|
Tub 2
|
20 (60.7)
|
16 (61.6)
| |
|
Por
|
1 (3.0)
|
1 (3.8)
| |
|
Muc
|
0 (0)
|
2 (7.7)
| |
|
Sci
|
1 (3.0)
|
0 (0)
| |
|
Stage (%)
|
0.441
|
|
II
|
11 (33.3)
|
11 (42.3)
| |
|
III
|
11 (33.3)
|
6 (23.1)
| |
|
IV
|
11 (33.3)
|
9 (34.6)
| |
|
Lymph nodes, n (range)*
|
9 (1–23)
|
19 (6–40)
|
< 0.01
|
|
Resection status (%)
|
< 0.01
|
|
D1
|
3 (9.1)
|
0 (0)
| |
|
D2
|
12 (36.4)
|
1 (3.8)
| |
|
D3
|
18 (54.5)
|
25 (96.2)
| |
|
Recurrence (%)
|
0.424
|
|
Yes
|
9 (40.9)
|
4 (23.5)
| |
|
No
|
13 (59.1)
|
13 (76.5)
| |
|
Observation period, days (range)*
|
1516 (17–4773)
|
608 (52–1601)
| |
- *median, TDT = trans-anal decompression tube, CMS = colonic metallic stent
